The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Voltage-gated potassium channels as therapeutic targets
Open accessAbstract
The human genome encodes 40 voltage-gated K+ channels (KV), which are involved in diverse physiological processes ranging from repolarization of neuronal and cardiac action potentials, to regulating Ca2+ signalling and cell volume, to driving cellular proliferation and migration. KV channels offer tremendous opportunities for the development of new drugs to treat cancer, autoimmune diseases and metabolic, neurological and cardiovascular disorders. This Review discusses pharmacological strategies for targeting KV channels with venom peptides, antibodies and small molecules, and highlights recent progress in the preclinical and clinical development of drugs targeting the KV1 subfamily, the KV7 subfamily (also known as KCNQ), KV10.1 (also known as EAG1 and KCNH1) and KV11.1 (also known as HERG and KCNH2) channels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Mergla K + channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway
Wang, X., Hockerman, G. H., Green, H. W., Babbs, C. F., Mohammad, S. I., Gerrard, D. E., Latour, M. A., London, B., Harmon, K. M., & Pond, A. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-5350fje · Cited by 36
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania
Redrobe, J. P., & Nielsen, A. N. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.027 · Cited by 34
Wang, K., McIlvain, B., Tseng, E., Kowal, D. M., Jow, F., Shen, R., Zhang, H., Shan, Q. J., He, L., Chen, D. A., et al. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.525 · Cited by 34
Methionine aminopeptidase 2 inhibition: antiangiogenesis and tumour therapy
Bradshaw, R. A. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.1.1 · Cited by 34
Benzopyran sulfonamides as KV1.5 potassium channel blockers
Lloyd, J., Atwal, K. S., Finlay, H. J., Nyman, M. C., Huynh, T., Bhandaru, R., Kover, A., Schmidt, J. B., Vaccaro, W. D., Conder, M. L., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.020 · Cited by 32
Nakashima, H. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.12.016 · Cited by 31
Regan, C. P., Kiss, L., Stump, G. L., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127654 · Cited by 31
The Role of Antiarrhythmic Drug Therapy for the Prevention of Sudden Cardiac Death
Kamath, G. S., & Mittal, S. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.12.001 · Cited by 30
Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators)
Lü, Q., Peevey, J. F., Jow, F., Monaghan, M. M., Mendoza, G., Zhang, H., Wu, J., Kim, C. Y., Bicksler, J., Greenblatt, L., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.12.031 · Cited by 30
Voltage-Dependent Potassium Channels in White Adipocytes
Ramírez-Ponce, M. P., Mateos, J. C., Carrión, N., & Bellido, J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0880 · Cited by 29
Plosker, G. L., & Scott, L. J. (2006) · CNS Drugs · doi:10.2165/00023210-200620070-00005 · Cited by 26
Impact of Novel Screening Technologies on Ion Channel Drug Discovery
Lü, Q., & An, W. F. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708783877735 · Cited by 24
Magyar, J., Horváth, B., Bányász, T., Szentandrássy, N., Birinyi, P., Varró, A., Szakonyi, Z., Fülöp, F., & Nánási, P. P. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0047-4 · Cited by 23
Discovery and synthesis of tetrahydroindolone-derived carbamates as Kv1.5 blockers
Fluxe, A., Wu, S., Sheffer, J. B., Janusz, J. M., Murawsky, M. K., Fadayel, G. M., Fang, B., Hare, M., & Djandjighian, L. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.059 · Cited by 21
Börjesson, A., Karlsson, T., Adolfsson, R., Rönnlund, M., & Nilsson, L. (1999) · Neuropsychobiology · doi:10.1159/000026602 · Cited by 15
SNAP-251–180 enhances insulin secretion by blocking Kv2.1 channels in rat pancreatic islet β-cells
Zhuang, G., Wu, W., Liu, F., Ma, J., Luo, Y., Xiao, Z., Liu, Y., Wang, W., & He, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.059 · Cited by 14
Bauer, A., Koch, M., Kraft, P., Becker, R., Kelemen, K., Voss, F., Senges, J. C., Gerlach, U. V., Katus, H. A., & Schoels, W. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0522-y · Cited by 14
Jow, F., Shen, R., Chanda, P. K., Tseng, E., Zhang, H., Kennedy, J. D., Dunlop, J., & Bowlby, M. R. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107307448 · Cited by 11
Pharmacological therapy for atrial fibrillation: current options and new agents
Viswanathan, M. N., & Page, R. L. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902773410 · Cited by 8
Cited by
The chemistry, physiology and pathology of pH in cancer
Swietach, P., Vaughan-Jones, R. D., Harris, A. L., & Hulikova, A. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0099 · Cited by 539
The roles of K+ channels in cancer
Pardo, L. A., & Stühmer, W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3635 · Cited by 477
Self-citationFehrentz, T., Schönberger, M., & Trauner, D. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201103236 · Cited by 377
Mitochondrial Channels: Ion Fluxes and More
Szabo, I., & Zoratti, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00021.2013 · Cited by 321
Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome
Sun, J., & MacKinnon, R. (2017) · Cell · doi:10.1016/j.cell.2017.05.019 · Cited by 305
Metadata
- Authors
- Wulff, H., Castle, N. A., & Pardo, L. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-12
- Volume
- 8
- Issue
- 12
- Pages
- 982-1001
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2021704663
- Cited by
- 799
- References
- 219
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.